| 生物活性 | |||
|---|---|---|---|
| 描述 | PF-06291874, characterized as a powerful, orally administered, non-peptide antagonist of the glucagon receptor, is being researched for its potential application in managing type 2 diabetes mellitus (T2DM)[1].[2]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 1.99mL 0.40mL 0.20mL | 9.93mL 1.99mL 0.99mL | 19.86mL 3.97mL 1.99mL | 
| 参考文献 | 
|---|